MedTrace Logo

Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer

NCT06307184 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 530

Last updated 2026-02-23

No results posted yet for this study

Summary

This study will assess the convenience of the natural proliferative phase frozen embryo transfer (NPP-FET) in terms of number of number of appointments needed before cycle scheduling.

Conditions

  • Frozen Embryo Transfer

Interventions

PROCEDURE

Natural proliferative phase frozen embryo transfer

When endometrial thickness is above 7 mm, vaginal micronized progesterone will be administered 400mg 12/12h when the dominant follicle is at least 13 mm, serum estradiol (E2) levels are \>80 pg/ml, and serum progesterone levels are \<1.5ng/ml. Embryo transfer will be performed on the fifth day of progesterone.

Sponsors & Collaborators

  • Gedeon Richter Ltd.

    collaborator INDUSTRY

  • Instituto Valenciano de Infertilidade de Lisboa

    lead NETWORK

Principal Investigators

  • Ana R Neves, MP · Instutito Valenciano de Infertilidade de Lisboa (IVI-RMA Lisboa)

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-23
Primary Completion
2026-09-30
Completion
2026-12-31

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06307184 on ClinicalTrials.gov